Career Choices for Developing Neurons by Anderson, David J.
These cloned immor-
talized precursor 
cells, with their 
characteristic nubbin-
like protrusions, could 
become either sym-
pathetic neurons or 
adrenal chromaffin 
cells. They have been 
co-cultured with the 
fan-like cells, visible 
on the right, that har-
bor the defective 
retrovirus that injects 
the immortalizing 
gene into the precur-
sor cells. 
Career Choices for 
Developing Neurons 
by David J. Anderson 
The study of the brain has become one 
of modern biology's last frontiers. We are fas-
cinated by how we think, remember, and feel, 
and how such a complex machine capable of 
doing these things can assemble itself. It is the 
latter problem that I'm going to address-how 
the brain gets built. There are many aspects to 
this problem, but one of the central questions is 
the problem of neuronal diversity. The brain 
contains an enormous number of different types 
of neurons, not just one generic kind of nerve 
cell. The great neuroanatomist Santiago Ramon 
y Cajal recognized many of these different types 
of nerve cells almost a century ago. These neu-
rons not only have different shapes, which were 
visible to Ramon y Cajal in the microscope, but 
are also specialized biochemically in ways that we 
can now observe with more modern methods. 
This great diversity of form subserves a diversity 
of function, which is extremely important for the 
way your brain works. Taken together, these 
different kinds of neurons amount to more cell 
types than are found in all the rest of the body 
combined. 
How does a developing cell in the embryonic 
brain decide which type of neuron it's going to 
become? Does each precursor cell "know" intrin-
sically what type of neuron it is going to be, 
right from the start, or does it have a career 
choice? If precursors do have choices, what are 
they, and what mechanisms control the actual 
choice? To what extent are the choices reversi-
ble, once made? These are some of the specific 
questions that my laboratory has set out to 
address. 
How does a 
developing cell 
in the embryonic 
brain decide 
which type 
of neuron it's 
going to become? 
Our general plan of attack is quite straight-
forward. First we isolate the neuronal precursor 
cells. Then, under controlled laboratory condi-
tions where we can vary the cells' milieu, we 
examine the developmental fates available to 
these cells. Thus we can determine the relative 
contributions of both the cell's local environment 
and its internal genetic programming, to its 
choice of developmental fate. In a sense, we 
are asking the nature versus nurture question 
at the cellular level. 
Unfortunately, the brain is really just too 
complicated a structure to study in this reduc-
tionistic way. The brain contains berween 
100,000 and 1,000,000 different types of neu-
rons, depending on how you define neuronal cell 
type. To attack this problem, therefore, we've 
had to break it up into bite-sized pieces that are 
relatively solvable. We've done that by making 
two simplifying decisions. First, we've decided 
not to work on the brain itself, but on another 
part of the nervous system called the peripheral 
nervous system. Second, we only work on two 
kinds of cells within that part of the nervous 
system. 
The peripheral, or autonomic, nervous system 
is the part that lies outside of the brain and spi-
nal cord, which together compose the central ner-
vous system. The central nervous system con-
trols conscious actions, such as deciding to call 
a friend, remembering the phone number, and 
picking up the telephone. The peripheral ner-
vous system controls important, but unconscious, 
bodily functions such as heart rate, digestion, 
and reproductive activity. So even though you 
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The central nervous 
system contains 
between 100,000 and 
1,000,000 types of 
nerve cells. Many of 
these cell types were 
first recognized by 
their shapes almost a 
century ago by Ramon 
y Ccijal. Dendrites col-
lect incoming signals 
from other cells, while 
the axon carries the 
cell's electrical out-
put. The cell body 
houses the nucleus 
and the cell's meta-
bolic and secretory 
machinery. 
, 
manque. 
might have been 
a neuron, but 
during develop-
ment it missed 
its calling. 
can't solve differential equations with these neu-
rons, they're still very important to you. 
Of the two particular cell types that we work 
on, one is the "sympathetic neuron" that exists in 
the little ganglia, or clusters of nerve cells, that 
run in two chains up and down either side of the 
spinal cord. Sympathetic neurons, like most oth-
er kinds of neurons, have both the long, thread-
like structures (" processes") that are the wires of 
the nervous system, and the ability to make the 
connections (" synapses") that regulate the passage 
of nerve impulses from cell to cell. Each neuron 
actually has two types of processes-several com-
paratively short dendrites that collect incoming 
signals, and one very long axon that carries the 
cell's electrical output to its target tissue, such 
as the heart muscle. 
The other kind of cell is an endocrine or 
secretory cell, called a chromaffin cell, found in 
the adrenal gland. The adrenal gland, a nutlike 
object that sits on top of the kidney, is really a 
gland within a gland. The outer zone is the 
adrenal cortex, which makes steroid hormones. 
The chromaffin cells exist in an inner zone called 
the adrenal medulla. They synthesize adrenaline, 
releasing it into our bloodstream when we're 
frightened or excited, accelerating our heart rate 
and preparing us to flee or fight. Chromaffin 
cells are little rounded cells without processes. 
These two cell types appear very different 
superficially, but actually they are quite similar. 
Chromaffin cells, although they lack axons and 
dendrites, have much of the same molecular 
machinery as n,eurons-that involved in the syn-
thesis, storage, and release of the catecholamines, 
Right: A section 
through a sympathetic 
ganglion. The purple 
blobs are sympathet· 
ic·neuron cell bodies, 
and the whitish pep-
peroni.like structures 
within them are the 
nuclei. (The axons 
and dendrites aren't 
visible.) The stream 
of smaller cells cross-
ing the top of the 
photo and proceeding 
down its left-hand 
side are the glial cells 
associated with a 
bundle of nerve fibers. 
Far right: A section 
through the adrenal 
medulla. The chromo 
affin cells are clus-
tered around blood 
vessels (white voids) 
so that their adrena· 
line goes directly into 
the bloodstream. The 
cell bodies are indis· 
t inct, but the darker 
nuclei are clearly 
visible. 
a biologically imporram fami ly of chemicals. 
(Like a produccion pipeline in a chemical factOry, 
this machinery makes dopamine, a simple cate-
cholamine, from raw materials. Additional steps 
down the pipe convert dopamine into noradrena-
line, and that into adrenaline. This pipeline 
occurs in several cell types. The cells open valves 
at various points along the pipeline to draw off 
different products-some central-nervous-system 
neurons make dopamine, while the sympathetic 
neurons prod uce noradrenaline, and the chromaf-
fi n cells secrete adrenaline.) Funhermore, chrom-
affin cells and sympathetic neurons both have 
eleccrically excitable membranes. 
Thus it is accurate to say that a chromaffin 
cell is a neuron manque. It might have been 
a neuron, bur during development it missed its 
calling. In comrast to most other specialized cell 
types in the body, however, chromaffin cells re-
rain throughout life the option to change their 
career in a way that many of us might envy . If 
these cells are taken out of rhe organism and ex-
posed to a substance called nerve growth factor 
(NGF), they are able ro drop their secrerory-cell 
properties and acquire the propenies of a nerve 
cell. They'll throw out processes- develop den-
drites and axons-and make synapses. This 
involves not only a change in rhe shape ancl size 
of the cell , bur also a change in the set of genes 
the cell rums on in its nucleus. This plasticity is 
an unusual phenomenon, and adds an extra ele-
ment of interest to this developmental system. 
It may also be relevant, at some level, to under-
standing other forms of neutal plasticity, such 
as regeneration and learning. 
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A road map for 
precursor.cell migra· 
tion. The cells peel 
off the developing spi· 
nal cord in a wave. 
Some pull over and 
park along a nearby 
blood vessel to form 
the sympathetic gan· 
glia, while others con· 
tinue on to the adre· 
nal gland. 
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The precursor 
cells peel off the 
neural tube and 
migrate down-
ward through 
the embryo like 
tiny parachut-
ists leaping from 
a moving 
airplane. 
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In the early 1980s, the functional similarities 
between sympathetic neurons and chromaffin 
cells, as well as the ability of adult chromaffin 
cells to convert into neurons, suggested to Allison 
Doupe, now a research fellow in biology, and 
Paul Patterson, now professor of biology (both 
then at Harvard) that these two cell types might 
arise from a common progenitor during embry-
onic development. We therefore set out to test 
this hypothesis in rat embryos. 
According to classical descriptive embryology, 
the earliest undifferentiated precursor cells in this 
lineage can first be identified about midway 
through gestation. The cells become apparent 
when they detach themselves from the dorsal 
side of the neural tube (the embryonic spinal 
cord) to form a transient structure called the 
"neural crest." The neural crest first appears just 
behind the brain and propagates as a wave along 
the neural tube to the tail. The precursor cells 
peel off the neural tube and migrate downward 
through the embryo like tiny parachutists leaping 
from a moving airplane. Some of the cells stop 
migrating very quickly and form a chain of small 
clumps along a nearby blood vessel, where they 
eventually become sympathetic neurons. Others 
continue their migration downward to invade the 
developing adrenal gland, where they proliferate 
and become chromaffin cells. It's like the pio-
neers who came west-some stopped in Colo-
rado, while others continued on to California. 
We can begin to see differences in the cells' 
development shortly after the migration ends. 
We and the Patterson laborarory have developed 
specific monoclonal antibody stains for these vari-
ous cell types. Cells in the ganglia bind to anti-
bodies specific for sympathetic neurons, whereas 
cells in the adrenal gland bind to antibodies 
specific for chromaffin cells. These anatomical 
observations support the idea of a common pre-
cursor, and suggest that the fate of a cell might 
be controlled by the environment into which it 
migrates. 
One way to test this hypothesis would be 
to transplant these cells to a different part of 
the embryo, and see how they developed there. 
However, this kind of experiment is very difficult 
to perform, especially in something as small as a 
rat embryo. As an alternative, therefore, we de-
cided to isolate these cells from the embryo and 
put them in culture dishes. In that way we are 
able to watch them develop in an environment 
that we can control by adding different factors to 
the culture medium. 
We isolate the precursor cells just after their 
migration into ~he adrenal gland. First, we dis-
sect out the glands using very fine instruments. 
The experimental 
scheme. "E14.5" is 
the number of days 
into gestation-a rat 
comes to term in 
about three weeks. 
"DEX" is a synthetic 
gllicocorticoid that 
converts the precur-
sors to chromaffin 
cells; "FGF" stands 
for Fibroblast Growth 
Factor, which drives 
the conversion to neu-
rons; "CON" is a con-
trol culture to which 
neither substance is 
added and whose 
cells start to become 
neurons but don't go 
very far. 
These sections 
through a rat embryo, 
magnified 70x, were 
made at embryonic 
day 14.5, about one 
day after migration 
begins. The migration 
will continue for three 
or four days longer, 
but differences can 
already be seen 
among the crest cells 
that have reached 
their destinations. 
Top: Tyrosine hydrox-
ylase recognizes both 
sympathetic gangli" 
(5G) "nd adrenal 
medulla (AM) cells. 
Middle: B2, a mono-
clon,,1 antibody 
developed by .Jane 
Dodd at Columbia, 
recognizes sympath-
etic neurons only. 
Bottom: 5A-1, a mono-
clonal antibody devel-
oped by .Josette Car-
nahan and Paul Pat-
terson at Caltech,is 
specific for chromaf-
fin cells. The cells 
still look alike, and 
without these antibod-
ies, it would be very 
difficult to tell them 
apart. 
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We then dissociate the glands into a suspension 
of individual cells, using proteolytic enzymes that 
cleave the bonds holding the cells together with-
out damaging the cells themselves. This leaves 
us with a soup containing the cells we're interest-
ed in-the migrating precursors-mixed in with 
all the other adrenal cells. We use other specific 
antibodies to tag the precursor cells' surface with 
a fluorescent dye. We then run the soup 
through an extremely sophisticated and very 
expensive instrument called a Fluorescence-Acti-
vated Cell Sorter (FACS)-a part of the biology 
division;s cell-sorter facility, which is run by 
Associate Professor of Biology Ellen Rothenberg. 
The F ACS dribbles our soup through a laser 
beam. The soup is so dilute that each droplet 
contains, on average, only one cell. The laser 
excites the fluorescent dye, making the tagged 
cells glow. The other cells don't glow. If the 
machine senses that a tagged cell has been 
excited, it diverts that droplet into one rube. 
The other droplets fall into another tube. The 
precursors constitute about five percent of the 
starting cell population, so we obtain about a 
20-fold purification. 
We can now grow these isolated cells in a 
culture dish and watch how they develop under 
different environmental conditions. We divide 
the cells into different dishes whose culture 
media contain not only the nutrients and goodies 
necessary to keep the cells healthy, but also 
specific molecules whose influence on the cells' 
fate we would like to determine. We find that 
in order to get the precursors to develop into 
chromaffin cells, as 1hey would have normally 
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Precursor cells, 
stained brown, caught 
in the act of invading 
the adrenal gland. 
These cells will set up 
housekeeping in the 
gland's center, com-
pletely surrounded by 
the cells of the adre-
nal cortex. The 
developing adrenal 
gland is the darker 
blue region in the 
center of the picture; 
the top of the kidney 
is visible below it. 
The white oval to the 
adrenal gland' s left is 
the dorsal aorta, and 
a portion of the gut 
can be seen to the 
gland's right. 
Above: A suspension 
of precursor cells 
from the FACS, as 
seen under phase-
contrast microscopy_ 
Below: The same cells 
with their fluorescent 
antibodies aglow. Vir-
tually every cell in the 
suspension is a 
tagged precursor. • . 
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done in the embryo, we have to add substances 
called g lucocorticoid hormones to the culture 
medium. If we don ' t do this , the cells begin to 
differentiate into sympathetic neurons, extending 
little nubbinlike processes, but they don ' t devel-
op very far. We can push the cells all the way 
into bona fide neurons by adding [\\'0 proteins 
called Fibroblast Growth Facror (FG F) and 
Nerve Growth Factor (NGF). This result 
strongly suggests that individual precursor cells 
have at least twO possible alternatives-they can 
develop into chromaffin cells or into sympathetic 
neurons. Moreover, the choice does, in fact , 
appear to be influenced by factors in the cells ' 
environment. In a complementary experiment, 
Patterson and graduate student J osette Carnahan 
exposed precursor cells taken from the sym-
pathetic ganglia to FGF, NGF, and glucocor-
ticoids and obtained similar results. 
Why should glucocorticoid hormones be 
necessary for the precursors to develop intO 
chromaffin ce lls? This resu lt makes sense because 
these hormones are secreted by the cells of the 
adrenal cortex, through which the invad ing crest 
cells migrate en route ro forming the adrenal 
medulla within. (I should point out that this 
process of migration , invasion, and proliferation 
is very similar to what happens when a cancer 
becomes metastatic and invades diffetem parts 
of the body from a primary tulTIor. This is an 
example of how understand ing fundamental bio-
logical mechanisms is relevant to undcrsranding 
clinical specifics of d isease,) 
Glucocorricoids are a particular type of stc-
roid hormone. The steroids are a fam ily of fatry 
Top: Undifferentiated 
preC\.lrsor cells. The 
arrows point to _he 
nubbinlike processes. 
Middle: Adding FGF 
changes the cells to 
neurons. Here three 
neurons have grown 
up in a cluster. The 
three gray blobs in the 
white body are the 
three nuclei. Thread· 
like processes are 
also visible. 
Bottom: Adding glu· 
cocorticoids produces 
a chromaffin cell. The 
gray banana shape is 
the nucleus. All three 
photos are magnified 
2S0x. The top photo 
is of unstained living 
cells, but the cells in 
the other two photos 
have been fixed and 
stained with fluores· 
cent antibodies. 
On the one 
hand, the pre-
cursor cell is 
endowed with 
a limited reper-
toire of potential 
fates; on the 
other hand, it 
must choose one 
fate from among 
this repertoire. 
molecules very similar to cholesterol. This family 
includes the sex steroids such as estrogen, and 
the anabolic steroids (used illegally by some ath-
letes), as well as the glucocorticoids such as cor-
tisol. Cortisol is the main glucocorticoid secreted 
by the adrenal cortex, and plays a number of 
roles in the adult, including controlling the in-
flammatory response. In the embryo, however, 
one of its functions is apparently to drive the 
neural crest cells that migrate into the adrenal 
gland down the chromaffin pathway of differenti-
ation. And the precursors are migrating right 
into the belly of the beast-they're crawling 
right into the site where the steroid is synthe-
sized, where its local concentration is extremely 
high. Thus the ourer part of the gland-within-
a-gland (the cortex) controls the development 
of the inner part (the medulla). 
What about those cells that don't migrate 
into the adrenal gland, but become neurons in 
the sympathetic ganglia? We would like to 
think from our results that FG F is concentrated 
in the ganglia, in the same way that glucocor-
ticoids are concentrated in the adrenal gland. 
The cells that stayed in the ganglia would there-
fore be exposed to FGF. However, we don't yet 
know if this is actually true. We are now using 
sophisticated molecular-biological techniques to 
see if FG F is really concentrated in the ganglia 
at the time that the neurons are differentiating. 
This work shows how a peripheral-nervous-
system cell can choose between two different 
fates, according to signals in the environment 
into which it migrates. We think that the same 
type of mechanism we have observed may well 
be true for central-nervous-system precursors that 
give rise to different kinds of neurons in the 
brain. However, this isn't the whole story. 
Most other cells in the embryo-or even 
in the neural crest, whose cells also go on to 
become the bones in your face, the pigment-
producers in your skin, the insulation in your 
nerves, and many other cell types-would not 
rum into sympathetic neurons or chromaffin cells 
in response to the hormones we've added to our 
culture dish. This is because the cells have to be 
conditioned, by their previous history, to respond 
to particular hormones in a particular way. Thus 
the cells that arrive at the sympathetic ganglia or 
the adrenal gland have already made, we believe, 
several earlier decisions that limit their choice of 
fate to only two final options. It's like going out 
for dinner-first you choose a particular kind of 
restaurant: Italian, Chinese, or Mexican; then, 
once you arrive there, you're committed to a par-
ticular type of food, but you can still choose from 
among the various dishes on the menu. The 
neuron-chromaffin decision is analogous to choos-
ing among the different dishes-it's one of the 
final steps. To continue the analogy even fur-
ther, the chromaffin cell's plasticity means that 
even after it has ordered dinner and started to 
eat, it can still send its choice back to the 
kitchen and order something else. 
The neuron-chromaffin development decision 
involves an interplay between the cell's internal 
genetic programming and specific signals in the 
local environment. On the one hand, the pre-
cursor cell is endowed with a limited repertoire 
of potential fates; on the other hand, it must 
choose one fate from among this repertoire. 
What genes and proteins actually determine the 
specific repertoire of possible fates? What genes 
and proteins actually select a particular fate? 
These are the big questions we are pursuing 
in an effort to understand the molecular biology 
of this developmental system. 
With the exception of the immune system, 
it is generally believed that every cell type in the 
human body, be it a neuron or a liver cell, con-
tains in its nucleus the same set of 100,000 
genes. Only a small fraction of those genes are 
active in anyone cell type, however, and what 
distinguishes one type from another is the partic-
ular set of genes that the cell chooses to turn on. 
So at the molecular level, choosing the neuronal 
fate means that the precursor cell has decided to 
turn on some genes that are characteristic of neu-
rons. Conversely, choosing the chromaffin fate 
means that the cell has decided to turn on 
chromaffin-specific genes. Our lab and others 
have cloned genes re'i'resentative of each of these 
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Left: A culture of 
immortalized precur-
sor cells. 
Middle: A culture of 
neurons made from 
the immortalized pre-
cursors. 
Right: Processes from 
these neurons grow to 
the farthest reaches 
of the dish. All three 
photos are magnified 
100x. 
Each gene is 
like a lamp 
with a dimmer 
switch. 
two complementary classes. This enables us to 
study the ways in which these genes are turned 
on and off during development. 
We have found that these genes appear to be 
regulated at two main levels. At one level, there 
is "all or nothing" control-in tissues unrelated 
to the nervous system, such as the liver, these 
genes are completely shut off. The second level 
of control is "more or less" -in chromaffin cells 
and sympathetic neurons, these genes are either 
turned up or turned down, according to the cell's 
local environment. For example, the glucocor-
ticoid hormones that promote the differentiation 
of the precursor cell into a chromaffin cell act to 
both turn up the chromaffin-specific genes and 
turn down the neuron-specific genes. The con-
verse is ttue for environmental signals that pro-
mote neuronal differentiation, such as FG F and 
NGF. A useful analogy might be that each 
gene is like a lamp with a dimmer switch. In 
the liver, the lamp is completely unplugged. In 
the chromaffin-neuron precursor, the lamp has 
been plugged in. Later, during differentiation, 
the lamp is turned up or turned down by the 
dimmer switch, depending upon which pathway 
the cell chooses. The environmental signals-the 
glucocorticoids, FGF, and NGF-control the 
dimmer switch. 
One of the problems we've encountered in 
studying these precursor cells on the' molecular 
level is that only a small number of cells can be 
recovered from rat fetuses. We've circumvented 
this problem by applying recently developed 
techniques to immortalize these cells. We use 
a defective retrovirus as a disposable molecular 
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syringe to inject the precursor cells with a gene, 
called v-myc, that prevents them from differen-
tiating and allows them to divide forever in the 
culture dish. (The precursor cells normally 
divide a limited number of times, and then stop 
for good when they differentiate.) Thus we get 
an endless supply of cells for experiments at any 
time, without having to first perform long hours 
of dissection on large numbers of rat fetuses. 
Fortunately, these immortalized precursor cell 
lines still appear capable of undergoing differen-
tiation into sympathetic neurons when exposed 
to FGF. 
These cell lines have taught us something 
very interesting. Developing neurons eventually 
come to need NGF to survive, and they acquire 
this chemical dependence only after they have 
first been exposed to FGF. Thus it takes at least 
two different factors, acting at different times, to 
make a neuron. I like to call this a "relay mech-
anism." FGF starts the cell down a pathway of 
differentiation and takes it through one stage, 
setting it up to respond to NGF. The cell can 
then bind to NGF, and this second factor moves 
it further down the pathway of differentiation 
into a full-blown neuron. We don't yet know 
if this is true in vivo, but this hypothesis makes 
testable predictions. 
The reason that two factors may be needed 
is presumably that the first one is located in the 
ganglia, whereas the second one is located in the 
target tissues into which the axons grow-the 
heart muscle, Jor example. FGF starts the neu-
rons growing tq.eir axons toward the targets, 
while NGF takes over after the axons arrive, 
This therapy 
may not be 
limited to 
Parkinson's 
disease. 
helping to maintain the synapses. Neurons 
whose processes don't reach an NGF-secreting 
tissue die, which is one way that the developing 
nervous system ensures that the body gets wired 
up correctly. This two-stage process is somewhat 
analogous to sexual differentiation in people. 
The decision as to whether you will be male or 
female is made very early in your development, 
but you still have to go through puberty after 
you're born. FGF, we believe, controls the ini-
tial decision, and NGF controls the later matura-
tion that is the cellular equivalent of puberry. 
Although we developed these immortal cell 
lines for basic research, they may turn out to 
have an unexpected clinical relevance as well. 
You probably know someone who is afflicted 
with Parkinson's disease. It's a relatively com-
mon disease that usually begins late in life and 
is characterized by an uncontrolled tremor in the 
extremities, sometimes referred to as a pill-rolling 
tremor. This symptom occurs because a group 
of neurons in the brain-called the substantia 
nigra, because its cells contain a black pigment 
-dies. These neurons normally provide a neu-
rotransmitter, or chemical messenger, called 
dopamine to another part of the brain called the 
striatum. Without dopamine, the striatum neu-
rons don't function and the tremor occurs. 
Neurosurgeons have recently begun to pio-
neer a technique for treating Parkinson's disease 
in which the patient'S chromaffin cells-the very 
cells you've been reading about this whole time 
-are grafted into his or her brain to replace the 
dead neurons. Chromaffin cells were chosen for 
two reasons: one, they can manufacture dopa-
mine by opening the proper valve on the pipe-
line; and two, they ought to change into neurons 
in the brain just as they do in the culture dish. 
Although this technique appeared very promising 
at first, it now seems that the original idea of 
using the patient'S own chromaffin cells doesn't 
work very well. However, all is not lost. Ani-
mal experiments have shown that the technique 
works much better when fetal cells rather than 
adult cells are used. Presumably the immature 
cells can adapt to the new environment of the 
brain more readily. Cells apparently get old 
and set in their ways, just as people do. 
The routine therapeutic use of human fetal 
tissue isn't likely to happen in the foreseeable 
future for a number of reasons, ethical as well as 
technical. One way out of this dilemma would 
be to use immortalized fetal-cell lines such as the 
ones we have developed from rats. That is, if 
one could gain access to some human fetal adre-
nal glands just once, and immortalize those cells 
in the way that we've immortalized the rat cells, 
in theory one would have a continuous supply of 
human cells available for transplantation therapy; 
on tap, as it were. To this end, we're collaborat-
ing with Dr. Fred Gage of UC San Diego to test 
the viability and therapeutic value of our cell 
lines by transplanting them into rats that have 
been given a chemically induced form of Park-
inson's disease. Interestingly, this therapy may 
not be limited to Parkinson's disease. Under cer-
tain circumstances, these cells can also secrete 
acetylcholine, another neurotransmitter. Patter-
son is trying to determine if this ability can be 
exploited in analogous transplants to treqt 
Alzheimer's disease. 
In this article, I have tried to describe our 
approach to investigating an important question 
in neurobiology-how the different kinds of neu-
rons in the brain form during embryonic devel-
opment. We have seen that approaching this 
question requires making some decisions to sim-
plify the problem, and then combining a variety 
of techniques at both the cellular and molecular 
levels to find out what's going on. In this case, 
the answer to the question of nature versus nur-
ture is "a little of both." Nature, or the genetic 
programming of the precursor cell, endows the 
cell with a limited set of developmental options. 
Nurture, or the signals from the environment 
into which the cell migrates, helps it to choose 
from among these options. At the molecular 
level, this choice involves a complex network of 
regulatory genes that we now only dimly under-
stand. These developing cells, therefore, make 
choice~ in their lives just as we do, as we grow 
up. How satisfying, then, that understanding 
these little cells and their microworld may help 
us to one day treat diseases that make it so hard 
for many people to live their later years fully, 
when they should be enjoying the benefits of 
their own career choices.D 
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